Concomitant suppression of Th2 and Th17 cell responses in allergic asthma by targeting RORγt

Inhibition of RORγt suppresses both Th2 and Th17 cell responses in the airway, and this can become a potential therapeutic target for the treatment of allergic asthma.

http://ift.tt/2hl2bkb